Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality

Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Liver Transpl

Younossi ZM

doi: 10.1002/lt.25003.

Hepatology

Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study

Am J Gastroenterol.

Allen AM, Therneau TM, Mara KC, Larson JJ, Watt KD, Hayes SN, Kamath PS

doi: 10.14309/ajg.0000000000000401.

Further Publications

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

J Hepatol

Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A

doi: 10.1016/j.jhep.2021.07.035

Hepatology

Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study

J Gastroenterol Hepatol.

Sinn DH, Kang D, Chang Y, Ryu S, Cho SJ, Paik SW, Song YB, Pastor-Barriuso R, Guallar E, Cho J, Gwak GY

doi: 10.1111/jgh.14856.

Hepatology

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

Hepatology.

Kim D, Vazquez-Montesino LM, Li AA, Cholankeril G, Ahmed A

doi: 10.1002/hep.31158.

Hepatology

Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis

Dig Dis Sci.

Jara M, Dziodzio T, Malinowski M, Lüttgert K, Nikolov R, Ritschl PV, Öllinger R, Pratschke J, Stockmann M

doi: 10.1007/s10620-018-5360-5.

Hepatology

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease

Am J Gastroenterol.

Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, Fracanzani AL, Rosso C, Blanco MJG, Armandi A, Caviglia GP, Zaki MYW, Liguori A, Francione P, Pennisi G, Grieco A, Valenti L, Anstee QM, Bugianesi E

doi: 10.14309/ajg.0000000000000676.

Hepatology

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study

BMC Gastroenterol.

Pitisuttithum P, Chan WK, Piyachaturawat P, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VWS, Treeprasertsuk S

doi: 10.1186/s12876-020-01240-z.

Hepatology

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

Clin Gastroenterol Hepatol.

Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, Ferro D, Violi F, Sanyal AJ, Del Ben M

doi: 10.1016/j.cgh.2019.12.026.

Related content

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study